Peptides Explained

Peptides Explained

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(46)

Special Announcement: New Partnership for Peptides Explained

Special Announcement: New Partnership for Peptides Explained

In this special update episode, I'm announcing a new affiliate partnership between Peptides Explained and Offline Peptides. The mission of this podcast remains unchanged: providing clear, responsible,...

7 Touko 2min

Retatrutide Explained: The Triple Agonist Changing Obesity Medicine

Retatrutide Explained: The Triple Agonist Changing Obesity Medicine

Retatrutide may represent the next evolution in metabolic medicine. In this deep-dive episode of Peptides Explained, we break down the science behind the investigational "triple agonist" peptide that'...

6 Touko 12min

Minimal Effective Dose: The Key to Preventing Muscle Loss on GLP-1s

Minimal Effective Dose: The Key to Preventing Muscle Loss on GLP-1s

Using the minimal effective dose of GLP-1 medications may be the key to preserving muscle during weight loss. This episode explains how to implement it alongside nutrition and training.

28 Huhti 16min

GLP-1 Drugs... Are They Destroying Muscle? — What Semaglutide, Tirzepatide & Retatrutide Data Actually Shows

GLP-1 Drugs... Are They Destroying Muscle? — What Semaglutide, Tirzepatide & Retatrutide Data Actually Shows

A clinical deep dive into the muscle loss problem on GLP-1 medications. Semaglutide, tirzepatide, and the investigational triple agonist retatrutide all produce remarkable weight loss — but clinical t...

22 Huhti 22min

The Peptide Ban Is Ending: FDA Officially Begins Reclassification Process for BPC-157, TB-500 & More

The Peptide Ban Is Ending: FDA Officially Begins Reclassification Process for BPC-157, TB-500 & More

Breaking news episode. On April 15, 2026, the FDA formally initiated the reclassification process for BPC-157, TB-500, and other peptides restricted since 2023 — publishing a Federal Register notice a...

16 Huhti 25min

Grey Market Peptides – Safety, Testing, and What You Need to Know

Grey Market Peptides – Safety, Testing, and What You Need to Know

A clinical breakdown of grey market peptide safety, including contamination risks, testing standards, and how peptide quality impacts biological effects.

15 Huhti 17min

GHK-Cu Explained: The Science Behind the Copper Peptide for Skin, Hair, and Healing

GHK-Cu Explained: The Science Behind the Copper Peptide for Skin, Hair, and Healing

GHK-Cu Explained: The Science Behind the Copper Peptide for Skin, Hair, and Healing

9 Huhti 12min

BPC-157 Deep Dive: Healing Mechanism, Dosing, TB-500 Stack & Why It's BANNED in Sports

BPC-157 Deep Dive: Healing Mechanism, Dosing, TB-500 Stack & Why It's BANNED in Sports

A clinical deep dive into BPC-157 covering mechanism, recovery science, dosing patterns, TB-500 synergy, and why it is banned in professional sports.

2 Huhti 24min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
rss-pitaisko-erota
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
meditaatiot-suomeksi
psykopodiaa-podcast
terapiassa
katilon-kahvitunti
voi-hyvin-meditaatiot-2
rss-uplevel-by-sonja-hannus
rss-pt-paahtio
rss-kuumilla-aalloilla
rss-vapaudu-voimaasi
rss-sanelunpurku-podcast
junnut-pelissa
fitnessvastaanotto
rss-kehtaanko-kysya-podcast-aideille
selviytyjat-tarinoita-elamasta
paritellen
rss-rakas-mielenterveyteni